MIXED MESODERMAL (MULLERIAN) TUMOR

Clinical trials for MIXED MESODERMAL (MULLERIAN) TUMOR explained in plain language.

Never miss a new study

Get alerted when new MIXED MESODERMAL (MULLERIAN) TUMOR trials appear

Sign up with your email to follow new studies for MIXED MESODERMAL (MULLERIAN) TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Major trial aims to tame dozens of rare, neglected cancers with immune power combo

Disease control Ongoing

This study is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control many different types of rare, advanced cancers that have limited treatment options. It enrolled over 800 adults whose cancer progressed after standard therapy. The g…

Matched conditions: MIXED MESODERMAL (MULLERIAN) TUMOR

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 04, 2026 05:06 UTC

MIXED MESODERMAL (MULLERIAN) TUMOR

Get alerted when new MIXED MESODERMAL (MULLERIAN) TUMOR trials appear

Major trial aims to tame dozens of rare, neglected cancers with immune power combo